How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials (Q89458401)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 2019

Language	Label	Description	Also known as
English	How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials	scientific article published on 01 April 2019

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

0 references

How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

based on heuristic

inferred from title

author name string

Myrto T Samara

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

Adriani Nikolakopoulou

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

Georgia Salanti

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

Stefan Leucht

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

publication date

1 April 2019

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

Schizophrenia Bulletin

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

45

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

639-646

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining treatment refractoriness in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine in treatment-resistant schizophrenics

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in clinical effects of three phenothiazines in "acute" schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychopharmacologic treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of response to neuroleptic treatment in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in BPRS definitions of positive and negative symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment-Resistant Schizophrenia - The Role of Clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amisulpride, and atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose-ranging study vs. haloperidol. The Amisulpride Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional versus novel antipsychotics: changing concepts and clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age at onset of schizophrenia and neuroleptic dosage

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group).

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical profile of an atypical antipsychotic: risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are patients enrolled in first episode psychosis drug trials representative of patients treated in routine clinical practice?

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice guideline for the treatment of patients with schizophrenia, second edition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission in schizophrenia: proposed criteria and rationale for consensus

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What does the PANSS mean?

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of Brief Psychiatric Rating Scale scores

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardized remission criteria in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linking the PANSS, BPRS, and CGI: clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement-based psychiatry: definitions of response, remission, stability, and relapse in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definitions of response and remission in schizophrenia: recommendations for their use and their presentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should the PANSS be rescaled?

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elaboration on the early-onset hypothesis of antipsychotic drug action: treatment response trajectories

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PANSS should be rescaled

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International consensus study of antipsychotic dosing.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine synthesis capacity in patients with treatment-resistant schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Equipercentile linking of the BPRS and the PANSS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo response in antipsychotic clinical trials: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical predictors of therapeutic response to antipsychotics in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29982701

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/SCHBUL/SBY095

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29982701 AND SRC:MED&resulttype=core&format=json

5 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q89458401&oldid=1485968001"